PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 297.6K (Avg.)
-1.36 | -1.31
Highlights the firm's ability to meet near-term obligations and cover interest expenses. For conservative value investors, strong liquidity and coverage metrics are critical to avoid distress or forced dilution.
0.00
Below 1.0 – Potential short-term risk. Howard Marks would be alert about near-term solvency concerns.
0.00
Below 1.0 – Possible short-term liquidity stress. Howard Marks would caution about heavy reliance on selling inventory or raising cash quickly.
0.00
Below 0.4 – Weak immediate liquidity. Howard Marks would worry about meeting obligations if markets tighten.
-4.68
Negative interest coverage suggests negative EBIT or an overbearing interest burden – a major red flag for Benjamin Graham.
No Data
No Data available this quarter, please select a different quarter.